On behalf of GMaP Region 4, we wish you and yours a very Happy New Year. Hoping for a great 2020!
We're thankful to know and work with you!
Upcoming Events:
Rural Health Research Gateway | January 23, 2020
Rural Disparities in Health and Healthcare by Race and Ethnicity. This webinar will address differences in county-level premature death, individual-level differences in health status and differences in healthcare access and use by county racial and ethnic composition. Please learn more and register here
Indiana University, in partnership with the American Medical Women's Association and the Global Initiative Against HPV and Cervical Cancer | January 27-31, 2020
Us vs HPV 2020. This webinar series will address community and medical societies' initiatives to eliminate HPV and cervical cancer. Please learn more and register here
13th Health Disparities Conference | Xavier University of Louisiana | March 25-27, 2020
The 2020 conference, titled The Evidence of personal and Societal Determinants to Achieve Health Equity, will address the many complex factors including where we live, our environment, genetics, income and education. Please learn more here
Upcoming CURE Funding Deadlines:
CURE Deadline Reminder
NCI Kirschstein-NRSA Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (F31) | Applications are due April 8, Aug. 8, and Dec. 8, 2019 | PA-19-196
Diversity Research Supplements (New) | Apply between Feb. 1 – March. 30 and Oct. 1 - Dec. 1, 2019 | PA-18-586
Re-entry supplement FOA (New) | Apply between Feb. 1 – March. 30 and Oct.1 - Dec 1, 2019 | PA-18-592
Please use these updated Diversity Supplements Guidelines and Re-Entry Supplements Guidelines along with DS fact sheet to prepare your application.
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) | Applications are due Feb.12, June 12, and Oct. 12, 2019 | PAR-18-364 | PAR-18-365
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) | Applications are due Feb.12, June 12, and Oct. 12, 2019 | PAR-18-337 | PAR-18-336
NCI Transition Career Development Award to Promote Diversity (K22) | Applications are due Feb.12, June 12, and Oct. 12, 2019 | PAR-18-366 | PAR-18-367
Exploratory/Developmental Grants Program for Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) | Applications are due June 19 and Nov. 19, 2019 | PAR-18-655
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) | Application are due June 19 and Nov.19, 2018 | PAR-18-731
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) | Applications are due June 19 and Nov. 19, 2019 | PAR-18-654
National Cancer Institute Youth Enjoy Science Research Education Program (R25) | Application are due September 25, 2019 | PAR-17-059
Other Non-CURE Funding Opportunities
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01/R21 Clinical Trial Optional) | Applications are due June 5 and Oct 5, 2019 | PA-18-738 | PA-18-739
*NEW* Co-infection and Cancer (R01/R21 Clinical Trial Not Allowed) | Applications are due March 6, 2020 | PAR-20-062 | PAR-20-061
The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection.
Availability of Administrative Supplements to Support Acquisition and Annotation of Biospecimens from Racial/Ethnically Diverse Cancer Patients for the Development of Models for the Human Cancer Models Initiative (HCMI) | Applications are due July 25, 2019 | NOT-CA-18-076
Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required) | Application Due Date September 2019 | RFA-CA-18-026
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) | Applications due date: September 10, 2019 | PA-18-842
*NEW*Administrative Supplements to Support Cancer Disparity Collaborative Research Pre-application webinar: December 6th from 2:00 - 3:30 pm EST
Due dates: February 10, 2020 and September 10, 2020 Description: If you hold an active NCI-funded R01 (with at least 2 years of support remaining) and are interested in expanding your research to incorporate a cancer disparities research project, please consider submitting a proposal under FOA PA-18-842: Administrative Supplements to Support Cancer Disparity Collaborative Research. Please note that for this FOA, collaborative teams are required between a non-cancer disparities investigator (PI of the R01) and a collaborator who has minority health research or cancer disparities research expertise.
*NEW*The Sexual & Gender Minority Research Office (SGMRO) is pleased to announce the publication of a Notice of Special Interest (NOSI) regarding Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (NOT-OD-20-032).
Purpose: This Notice of Special Interest (NOSI) announces the availability of administrative supplements to provide funding for the expansion of existing research projects to incorporate sexual and gender minority (SGM) populations, which include, but are not limited to, those populations described in Notice NOT-OD-19-139. Basic, social, behavioral, clinical, translational, and health services research relevant to the missions of the sponsoring NIH Institutes or Centers (ICs) may be proposed in response to this solicitation. Potential applicants are also encouraged to review the FY 2017 Portfolio Analysis of NIH-funded SGM research to identify potential research gaps that may be relevant to this NOSI.
Application Due Dates are January 31, 2020 for FY 2020, January 25, 2021 for FY 2021, by 5:00 PM local time of applicant organization.
NCI Community Oncology Research Program (NCORP) | Research Bases | Community Sites | Minority/Underserved Community Sites Cooperative Agreement | Application Deadline is August 31, 2019 | RFA-CA-18-015 | RFA-CA-18-016 | RFA-CA-18-017
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) | Application due date November 7, 2019 | PAR-18-869
National Cancer Institute’s Healthcare Delivery Research Program (HDRP) supports several current funding opportunities listed down below:
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01/R21 Clinical Trial Optional) | PA-18-005 | PA-18-015
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01/R21 Clinical Trial Optional) | PA-18-004 | PA-18-014
Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional) | PA-17-495
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01/R21 Clinical Trial Optional) | PAR-18-246 | PAR-18-247
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01/R21/R03 Clinical Trial Optional) | PAR-18-008 | PAR-18-019 | PAR-16-337
Using Information Technology to Support Systematic Screening and Treatment of Depression in Oncology Practices (R01 Clinical Trial Optional) | PAR-18-493 | PAR-18-492
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21/R01 Clinical Trial Not Allowed) | Applications are due March 4, 2019, March 4, 2020, March 4, 2021| PAR-19-019 | PAR-19-018
The purpose of this initiative is to promote multidisciplinary research to understand the underlying causal factors and mechanisms that result in lung cancer disparities in U.S. health disparity populations.
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R01 Clinical Trial Not Allowed) | Applications are due December 4, 2018 |PAR-17-484
The purpose of this initiative is to support collaborative research between Tribal Epidemiology Centers and extramural investigators on topics related to minority health and health disparities in American Indian / Alaska Native (AI/AN) populations.
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) | The FOA will open for applications on January 5, 2019 and first standard due date is February 5, 2019 | PA-18-932
This FOA invites applications that seek to understand strategies to reduce disparities by increasing the uptake of evidence-based screenings across the adult lifespan. Research supported by this initiative should enhance the screening process related to use (1) in diverse populations, (2) in diverse clinical and community settings, and/or (3) with traditional, nontraditional, and/or allied health care providers.
NIH: Small Business Innovations for Health Disparities | Letters of Intent March 1 | Deadline for application is April 1 | RFA-MD-19-001
Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20, Clinical Trials Optional) | Application are due June 19, 2019, October 18, 2019, June 19, 2020, and October 18, 2020 | RFA-CA-19-034
Purpose: The goals for this FOA include developing translational research programs focused on investigating cancer disparities. The P20 grants will support feasibility and planning activities to build cancer disparities research programs, with the expectation that the research programs will become competitive for a full P50 SPORE. Reissue of RFA-CA-17-034 (resubmissions will be accepted). New restrictions: Due to a focus on understudied areas of cancer disparities, applications proposing prostate and breast cancer projects are not responsive for this issuance.
A pre-application webinar is planned for late April. A Notice will be published on the RFA with the date and a link to registration.
New Funding Opportunities
*NEW* Notice of Special Interest (NOSI): NCI's Research Interests to Improve Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment; NOT-CA-19-059
Contact: Sallie Weaver Application Due Date: This NOSI applies to due dates on or after September 25, 2019 through January 8, 2022. Applications related to this NOSI may be submitted using the following funding opportunity announcements or future reissuances: PAR-18-869, PAR-18-559, PA-19-056, PAR-18-290 An informational webinar is being planned. Please check our website for updates.
*NEW* Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization; PAR-19-352 (R01), PAR-19-355 (R21)
Contact: Michelle Mollica Next Submission Date: October 17, 2019 (R01); October 16, 2019 (R21) Expiration Date: September 8, 2022
*NEW* Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake; PAR-19-360 (R01), PAR-19-358 (R21), PAR-19-359 (R03)
Contact: Sarah Kobrin Next Submission Date: October 17, 2019 (R01); October 16, 2019 (R21 and R03) Expiration Date: September 8, 2022 (R01 and R21); July 17, 2022 (R03)
Software for Patient Navigation Through the Cancer Care Continuum (Topic 406): PHS2020-1 SBIR Contract Solicitation
Contact: Gurvaneet Randhawa Application Due Date: October 23, 2019
Dissemination and Implementation Research in Health, PAR-19-274 (R01), PAR-19-275 (R21), PAR-19-276 (R03)
Contact: Gila Neta, Wynne E. Norton, and David Chambers (from the DCCPS Implementation Science Team) Next Submission Date: October 5, 2019 (R01), October 16, 2019 (R21 and R03) Expiration Date: May 8, 2022
Funding Opportunity Announcement for Dissemination and Implementation Research in Health (R01/R21/R03) The purpose of this Funding Opportunity Announcement (FOA) is to support innovative approaches to identifying, developing, testing, evaluating and/or refining strategies to disseminate and implement evidence-based practices
New applications are due by October 5, 2019 by 5:00 PM local time of applicant organization. For more on standard applications deadlines visit: https://grants.nih.gov/grants/how-to-apply-application-guide/due-dates-and-submission-policies/due-dates.htm Program staff are available to answer questions. Contact information and funding resources are available online.
Funding Opportunity Announcement Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01/R03/R21) This FOA encourages research on how the health care delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent human papillomavirus (HPV) vaccine. Characteristics of the provider, parent/patient, and clinical setting can all affect whether a provider makes a recommendation, and whether that recommendation results in uptake of the HPV vaccine. This research requires expertise in cancer prevention, adult and childhood behavior, immunization promotion, and health care delivery.
Application Due Dates:
Sample Grant Applications The National Cancer Institute (NCI) frequently receives questions from investigators for examples of successfully funded grant applications. Several investigators and their organizations agreed to let the Division of Cancer Control & Population Sciences (DCCPS) programs post excerpts of their grant applications online.
Looking for additional funding opportunities? A full list of CRCHD funding opportunities as well as select NIH opportunities is available online.
Jobs/Training:
Postdoctoral T32 in Cancer Prevention and Control
We are now accepting applications for 2020
The NCI-funded T32 Training Program in Cancer Prevention & Control Research Program at the Wake Forest Baptist Comprehensive Cancer Center is seeking outstanding postdoctoral candidates for 2020. The program prepares trainees to become independent researchers in the field of cancer prevention and control with a particular focus on cancer survivorship, healthy lifestyles, and cancer care delivery. Program mentors have funded research in a wide range of relevant areas including health-related quality of life, lifestyle/behavior change (including tobacco, alcohol, diet, and physical activity), symptom management, access to treatment, health disparities, complementary and alternative interventions, late effects of cancer, and clinical care. Other key resources are provided by our Clinical and Translational Sciences Institute and NCI-funded Community Oncology Research Program (NCORP) Research base.
To learn more click here.
Training:
The National Institute on Minority Health and Health Disparities (NIMHD) will host the Health Disparities Research Institute (HDRI) from August 3-7, 2020, in Bethesda, MD. The online application system will open in early February 2020! The HDRI aims to support the research career development of promising early-career minority health and health disparities research scientists and to stimulate research in disciplines supported by health disparities science.
The program will feature:
- lectures on minority health and health disparities research
- mock grant review
- seminars and small group discussions
Institute participants will also have the opportunity to engage in sessions with NIH scientific staff involved in health disparities research across the various NIH institutes and centers.
Please note that applications will only be accepted from extramural scientists who meet NIH’s Early Stage Investigator (ESI) eligibility criteria. NIH and HHS staff, including persons doing fellowships/training at NIH or an HHS agency, are not eligible to apply.
Visit the HDRI webpage to learn more about the target audience, eligibility, selection criteria, and how to apply.
2020 BIOMEDICAL SCIENCE CAREERS STUDENT CONFERENCE
Location: The Westin Copley Place in Boston, Massachusetts
Date: Friday, April 3 and Saturday, April 4, 2020
The Biomedical Science Careers Program (BSCP) is asking for your help in identifying underrepresented minority postdocs (research and clinical); medical, dental and graduate students; post-baccalaureates; and college and community college students and High School Juniors and Seniors (particularly African-American, Hispanic/Latino or American Indian/Alaska Native students) who would benefit the most from attending the conference. Student participants should be seriously interested in or currently studying medicine, biomedical science or other science-related fields, such as chemistry, physics, biology, nursing, dentistry, pharmacy, engineering, biotechnology, physical therapy, public health, allied health or environmental science.
The aim of the Conference is to provide students/fellows with an opportunity to network with advisors/role models from the basic and clinical sciences, medicine, public health, academia and the biopharmaceutical industry. These advisors/role models will encourage students/fellows to complete advanced studies and provide concrete advice and information on available resources, professional opportunities and career paths in biomedical science and other science-related fields. The Conference also enables student/fellow participants to meet, inspire and network with one another. Additionally, each Conference offers breakout and plenary sessions, and a program featuring science resources, including internships, summer programs and after-school activities. Please see attached flyer for more information.
There is no fee to attend, but completion of a four-page application is required.
Application Deadline: February 4, 2020.
High School Application Deadline: December 12, 2019
Please share the attached flyer with eligible students.
Interested students should contact Hollie DeSilva at hollie_desilva@hms.harvard.edu to request an application.
HHS/NIH, National Cancer Institute (NCI) | Deadline is January 17, 2020
Intramural Continuing Umbrella of Research Experiences (iCURE). This program supports mentored research experiences for qualified students and scientists in the multidisciplinary research environment of the NCI campuses in Bethesda, Rockville and Frederick, Md. Please learn more here
HHS/CDC, Office of Minority Health and Health Equity (OMHHE) | Deadline is January 31, 2020
CDC Undergraduate Public Health Scholars (CUPS). This program consists of six internship opportunities at five partner institutions that seek to create public health workplace experiences to increase student interest in minority health and health professions. Please learn more here
Expanding NIH’s Definition of Socio-Economic Disadvantaged to be More Inclusive and Diversify the Workforce | NOT-OD-20-031
NIH recognizes it needs to encourage and enable careers of biomedical scientists with disadvantaged backgrounds and has considered a different approach to our definition of a disadvantaged background. Please learn more here
NIH and AHRQ Announce Changes to Policies, Instructions and Forms for Research Training Grant, Fellowship, and Career Development Award Applications
Please make applicants and potential applicants aware of these two important Notices. Please learn more about NOT-OD-20-026 and NOT-OD-20-033 and share them with your pool of applicants
Washington Student Achievement Council: American Indian Endowed Scholarship. Provides financial assistance to low-income Washington State students who have close social and cultural ties to an American Indian Tribe or community within the state. Application period is December to February 1, 2020: Learn more.
HHS/Indian Health Service (IHS): IHS Scholarship Program. This program offers three scholarships for undergraduate and graduate AI/AN students in order to educate and train health professionals to staff Tribal health programs. Application period opens in December. Learn more.
American Indian College Fund: Full Circle Scholarship. Provides financial assistance to AI/AN students seeking undergraduate and graduate degrees at Tribal colleges/universities or nonprofit schools. Application period is January 1 to May 31, 2020. Learn more.
Additional fellowships and training opportunities are available online. Check back often!
Tools & Resources
The NCI’s Office of Cancer Clinical Proteomics Research (OCCPR) Webinar | NCI’s Antibody Program | January 22, 2020
Please join the upcoming webinar that will provide a brief overview of NCI’s Antibody Portal by Dr. Tara Hiltke (Program Director at OCCPR).
The Antibody Portal has more than 500 available antibodies that have been designed and optimized, with the vast majority developed as fit-for-purpose reagents. Dr. Hiltke will talk about the antibody program, show participants how to navigate the newly re-vamped portal, as well as discuss the "Request For Target" antibody submission requirements through the NCI Antibody Characterization Program. Registration is required.
To learn more about the program and how to navigate the Antibody Portal we invite registrants to submit questions to LaToya.Kelly@nih.gov with "OCCPR Webinar: ANTIBODY PORTAL" in the subject line by 12:00pm EST on Friday, January 17, 2020. A limited number of questions submitted during the webinar will be addressed.
This webinar is brought to you by the Office of Cancer Clinical Proteomics Research (OCCPR). OCCPR aims to improve prevention, early detection, diagnosis, and treatment of cancer by enhancing the understanding of the molecular mechanisms of cancer, advancing proteome/proteogenome science and technology development through community resources (data and reagents), and accelerating the translation of molecular findings into the clinic
Visit the GMaP Group for additional tools and resources for researchers, such as links to biospecimens, biorepositories, and statistician tools!
News:
New Findings hint at therapies for African Americans with lung cancer
A study published in Nature Communications reveals that two genes tend to be mutated at higher rates in cancerous lung tissue samples taken from African Americans, hinting that these patients may benefit more from certain therapies targeting those genes. Please learn more here
Oncofertility: Creating a Bridge Between Cancer Care and Reproductive Health
Dr. Teresa Woodruff discusses the field that connects oncology with reproductive health, and the Oncofertility Consortium’s efforts to support clinicians, cancer patients, and families in understanding how cancer and its treatment affect fertility. Please learn more here
Additional news and a list of newsletters are available on our news page.
|
